Here are four observations:
1. A growing geriatric population, rising demand for minimally invasive surgery and increasing advancements of technologies will spur the SCS market growth.
2. Market barriers include the costliness of therapy as well as stringent regulatory approvals.
3. The market sees concentrated competition, with a few companies capturing large market shares.
4. Key market players include:
• Medtronic in Dublin, Ireland
• Nevro Corp. in Redwood City, Calif.
• Boston Scientific Corp. in Rolling Meadows, Ill.
• St. Jude Medical in Saint Paul, Minn.
More articles on devices:
Wisconsin’s Comprehensive Orthopaedics launches YouTube channel: 3 thoughts
Kator launches suture anchor system on a limited basis: 3 key notes
Dr. Nasser Ani uses SpineFrontier’s new minimally-invasive technology: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
